BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,419 | -14.9% | 4,217 | +12.9% | 0.01% | -16.7% |
| Q2 2023 | $119,227 | +10.4% | 3,734 | +5.9% | 0.01% | 0.0% |
| Q1 2023 | $107,966 | -29.7% | 3,526 | -10.2% | 0.01% | -14.3% |
| Q4 2022 | $153,624 | -15.9% | 3,928 | +2.4% | 0.01% | -22.2% |
| Q3 2022 | $182,747 | +23.1% | 3,836 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $148,492 | -20.6% | 3,836 | +17.5% | 0.01% | 0.0% |
| Q1 2022 | $187,027 | -82.1% | 3,264 | -75.1% | 0.01% | -50.0% |
| Q4 2021 | $1,043,381 | -8.4% | 13,093 | 0.0% | 0.01% | -17.6% |
| Q3 2021 | $1,139,222 | -31.2% | 13,093 | +1.8% | 0.02% | -26.1% |
| Q2 2021 | $1,655,854 | +90.9% | 12,865 | +18.7% | 0.02% | +76.9% |
| Q1 2021 | $867,393 | -5.6% | 10,837 | -3.7% | 0.01% | -7.1% |
| Q4 2020 | $919,185 | +253.8% | 11,259 | +6.7% | 0.01% | +180.0% |
| Q3 2020 | $259,839 | +98.2% | 10,554 | +125.4% | 0.01% | +150.0% |
| Q2 2020 | $131,096 | +55.6% | 4,682 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $84,276 | – | 4,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |